These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26084290)

  • 21. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.
    Zhang B; Wang J; Huang Z; Wei P; Liu Y; Hao J; Zhao L; Zhang F; Tu Y; Wei T
    Oncotarget; 2015 Dec; 6(42):44495-508. PubMed ID: 26517089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.
    Pridgeon JW; Olzmann JA; Chin LS; Li L
    PLoS Biol; 2007 Jul; 5(7):e172. PubMed ID: 17579517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.
    Agliarulo I; Matassa DS; Amoroso MR; Maddalena F; Sisinni L; Sepe L; Ferrari MC; Arzeni D; Avolio R; Paolella G; Landriscina M; Esposito F
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2570-9. PubMed ID: 26071104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.
    Pietrafesa M; Maddalena F; Possidente L; Condelli V; Zoppoli P; Li Bergolis V; Rodriquenz MG; Aieta M; Vita G; Esposito F; Landriscina M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E.
    Lee MH; Lee SE; Kim DW; Ryu MJ; Kim SJ; Kim SJ; Kim YK; Park JH; Kweon GR; Kim JM; Lee JU; De Falco V; Jo YS; Shong M
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E19-30. PubMed ID: 20926530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
    Chow AK; Cheng NS; Lam CS; Ng L; Wong SK; Wan TM; Man JH; Cheung AH; Yau TC; Poon JT; Law WL; Pang RW
    Mol Cancer; 2015 Apr; 14():80. PubMed ID: 25884645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells.
    Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas.
    Sánchez-Tilló E; Pedrosa L; Vila I; Chen Y; Győrffy B; Sánchez-Moral L; Siles L; Lozano JJ; Esteve-Codina A; Darling DS; Cuatrecasas M; Castells A; Maurel J; Postigo A
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.
    Rondanin R; Lettini G; Oliva P; Baruchello R; Costantini C; Trapella C; Simoni D; Bernardi T; Sisinni L; Pietrafesa M; Ponterini G; Costi MP; Vignudelli T; Luciani R; Matassa DS; Esposito F; Landriscina M
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2289-2293. PubMed ID: 29807796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.
    Tsai HY; Bronner MP; March JK; Valentine JF; Shroyer NF; Lai LA; Brentnall TA; Pan S; Chen R
    Cancer Lett; 2022 Nov; 549():215915. PubMed ID: 36113636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.
    Tian X; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Jiang YH
    FEBS J; 2014 Jun; 281(12):2805-19. PubMed ID: 24754231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guardian of the furnace: mitochondria, TRAP1, ROS and stem cell maintenance.
    Kadye R; Kramer AH; Joos-Vandewalle J; Parsons M; Njengele Z; Hoppe H; Prinsloo E
    IUBMB Life; 2014 Jan; 66(1):42-5. PubMed ID: 24382805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of apoptosis induction of thienopyrimidine compounds on KRAS and BRAF mutated colorectal cancer cell lines.
    Pédeboscq S; Gravier D; Casadebaig F; Hou G; Gissot A; Rey C; Ichas F; De Giorgi F; Lartigue L; Pometan JP
    Bioorg Med Chem; 2012 Nov; 20(22):6724-31. PubMed ID: 23063521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRAP1: a viable therapeutic target for future cancer treatments?
    Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
    Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
    Landriscina M; Amoroso MR; Piscazzi A; Esposito F
    Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
    Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
    BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.
    Agorreta J; Hu J; Liu D; Delia D; Turley H; Ferguson DJ; Iborra F; Pajares MJ; Larrayoz M; Zudaire I; Pio R; Montuenga LM; Harris AL; Gatter K; Pezzella F
    Mol Cancer Res; 2014 May; 12(5):660-9. PubMed ID: 24567527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of cyclooxygenase‑1 stimulates mitochondrial apoptosis through the NF‑κB signaling pathway in colorectal cancer cells.
    Ding L; Gu H; Lan Z; Lei Q; Wang W; Ruan J; Yu M; Lin J; Cui Q
    Oncol Rep; 2019 Jan; 41(1):559-569. PubMed ID: 30320345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
    Tabusa H; Brooks T; Massey AJ
    Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.